drug · antibody

volagidemab

Phase 2updated 3mo ago

by Remd Biotherapeutics Inc🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.

indications

Type 2 Diabetes

targets

Glucagon receptor

all catalysts(0)

nothing on the calendar yet

Trials studying volagidemab

phase1Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemabcompletedn=24
phase2Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetesrecruitingn=24

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 2m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

volagidemab

Phase 2updated 3mo ago

by Remd Biotherapeutics Inc🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.

indications

Type 2 Diabetes

targets

Glucagon receptor

all catalysts(0)

nothing on the calendar yet

Trials studying volagidemab

phase1Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemabcompletedn=24
phase2Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetesrecruitingn=24

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 2m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

volagidemab

indications

targets

all catalysts(0)

Trials studying volagidemab

News(0)

Report a data issue

comments(0)

volagidemab

indications

targets

all catalysts(0)

Trials studying volagidemab

News(0)

Report a data issue

comments(0)